Is Avalo Therapeutics, Inc. (AVTX) a Buy, Sell, or Hold?
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$18.5998 USD
$0.18 (0.98%)
- Volume
- 404.82K
- Average Volume
- 1.99M
- Market Capitalization
- $210.07M
- P/E Ratio
- -3.19
- Dividend Yield
- 0.00%
- Price Target
- $46.50
- Year High
- $24.27
- Year Low
- $4.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.66
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
53
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
68
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 774K
AVTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
AVTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-30 | M-Exempt | 12.65 | 2026-07-02 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-30 | M-Exempt | 8.04 | 2026-07-02 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-30 | M-Exempt | 8.04 | 2026-07-02 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-30 | M-Exempt | 12.65 | 2026-07-02 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-30 | S-Sale | 20 | 2026-07-02 |
| Philip Ron M | director | 2026-06-30 | A-Award | 18.48 | 2026-07-02 |
| Lind Kevin Robert | director | 2026-06-30 | A-Award | 18.48 | 2026-07-02 |
| Jain Rita | director | 2026-06-30 | A-Award | 18.48 | 2026-07-02 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-23 | M-Exempt | 8.04 | 2026-06-25 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-23 | M-Exempt | 8.04 | 2026-06-25 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-23 | S-Sale | 18 | 2026-06-25 |
| Philip Ron M | director | 2026-06-23 | A-Award | 17.83 | 2026-06-25 |
| Philip Ron M | 2026-06-23 | 0 | 2026-06-25 | ||
| Riley Jennifer | officer: Chief Strategy Officer | 2026-06-10 | F-InKind | 13.1 | 2026-06-12 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-06-10 | F-InKind | 13.1 | 2026-06-12 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-06-10 | F-InKind | 13.1 | 2026-06-12 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-06-10 | F-InKind | 13.1 | 2026-06-12 |
| Lind Kevin Robert | director | 2026-06-02 | A-Award | 13.96 | 2026-06-04 |
| Truex Samantha | director | 2026-06-02 | A-Award | 13.96 | 2026-06-04 |
| KAPLAN GILLA | director | 2026-06-02 | A-Award | 13.96 | 2026-06-04 |
| KANTOFF AARON | director | 2026-06-02 | A-Award | 13.96 | 2026-06-04 |
| Heffernan Michael Thomas | director | 2026-06-02 | A-Award | 13.96 | 2026-06-04 |
| Jain Rita | director | 2026-06-02 | A-Award | 13.96 | 2026-06-04 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-28 | M-Exempt | 8.04 | 2026-06-01 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-28 | M-Exempt | 8.04 | 2026-06-01 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-28 | S-Sale | 16 | 2026-06-01 |
| Riley Jennifer | officer: Chief Strategy Officer | 2026-05-21 | A-Award | 0 | 2026-05-26 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-21 | A-Award | 0 | 2026-05-26 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-21 | A-Award | 0 | 2026-05-26 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-21 | A-Award | 0 | 2026-05-26 |
| NEIL GARRY ARTHUR | director, officer: Chief Executive Officer | 2026-05-21 | A-Award | 0 | 2026-05-26 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-15 | M-Exempt | 12.65 | 2026-05-19 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-15 | M-Exempt | 12.65 | 2026-05-19 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-15 | S-Sale | 18.76 | 2026-05-19 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-07 | M-Exempt | 9.88 | 2026-05-11 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-07 | M-Exempt | 9.88 | 2026-05-11 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-07 | S-Sale | 24.1222 | 2026-05-11 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | M-Exempt | 13.43 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | M-Exempt | 8.04 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | M-Exempt | 8.04 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | M-Exempt | 13.43 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | S-Sale | 18.912 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | S-Sale | 19.7812 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | S-Sale | 21.2155 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | S-Sale | 22.6985 | 2026-05-07 |
| VARKI PAUL | officer: Chief Legal Officer | 2026-05-06 | S-Sale | 23.71 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | M-Exempt | 8.04 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | M-Exempt | 8.04 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | S-Sale | 18.5525 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | S-Sale | 19.2835 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | S-Sale | 20.76 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | S-Sale | 21.3698 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-05-06 | S-Sale | 22.5745 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-05 | M-Exempt | 12.65 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-05 | M-Exempt | 8.04 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | M-Exempt | 12.65 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | M-Exempt | 8.04 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | M-Exempt | 8.04 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | S-Sale | 18.0262 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | M-Exempt | 12.65 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | S-Sale | 19.6502 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | S-Sale | 21.1968 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | S-Sale | 22.406 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-05 | M-Exempt | 8.04 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-05 | M-Exempt | 12.65 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-05 | S-Sale | 16 | 2026-05-07 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-05-06 | S-Sale | 22.88 | 2026-05-07 |
| Chan Mitchell | director | 2026-05-06 | S-Sale | 22.88 | 2026-05-07 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-04-29 | S-Sale | 13.0925 | 2026-05-01 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-04-30 | S-Sale | 13.2261 | 2026-05-01 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-04-06 | M-Exempt | 12.65 | 2026-04-08 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-04-06 | M-Exempt | 12.65 | 2026-04-08 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-04-06 | S-Sale | 18.0122 | 2026-04-08 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-04-01 | S-Sale | 15.858 | 2026-04-03 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-04-01 | S-Sale | 16.8259 | 2026-04-03 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-04-02 | S-Sale | 17.0247 | 2026-04-03 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-04-02 | S-Sale | 17.5674 | 2026-04-03 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 8.04 | 2026-04-03 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 8.04 | 2026-04-03 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-04-01 | S-Sale | 16 | 2026-04-03 |
| Jain Rita | director | 2026-03-31 | A-Award | 14.93 | 2026-04-01 |
| Lind Kevin Robert | director | 2026-03-31 | A-Award | 14.93 | 2026-04-01 |
| Truex Samantha | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Truex Samantha | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| KANTOFF AARON | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| KANTOFF AARON | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| KAPLAN GILLA | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| KAPLAN GILLA | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| NEIL GARRY ARTHUR | director, officer: Chief Executive Officer | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| NEIL GARRY ARTHUR | director, officer: Chief Executive Officer | 2026-03-28 | F-InKind | 13.89 | 2026-03-31 |
| NEIL GARRY ARTHUR | director, officer: Chief Executive Officer | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-03-28 | F-InKind | 13.89 | 2026-03-31 |
| Sullivan Christopher Ryan | officer: Chief Financial Officer | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Chan Mitchell | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Chan Mitchell | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Goldman Jonathan | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Goldman Jonathan | director | 2026-03-28 | M-Exempt | 0 | 2026-03-31 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-03-16 | M-Exempt | 12.65 | 2026-03-18 |
| Doyle Mittie | officer: Chief Medical Officer | 2026-03-16 | M-Exempt | 8.04 | 2026-03-18 |